Clinical Trial Update: A Study Comparing the Injection Site Pain Experience After the Injection of 2 Different Solutions of Semaglutide With 2 Different Injection Pens, a Compound for the Treatment of Type 2 Diabetes and Obesity [Phase 2]

View source ↗

Summary

A Phase 2 study comparing injection site pain for two semaglutide formulations using two different injection pens in healthy volunteers and individuals with Typ…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity
• Overweight
• Type 2 Diabetes Mellitus

Drugs mentioned

• semaglutide (semaglutide)

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Healthy Volunteers Diabetes Mellitus, Type 2, Healthy Volunteers Overweight | Phase 2 | Status: COMPLETED | Results posted: 2020-08-04